Skip to content

Trends in Smoking-Attributable Disease Burden in China, 1990-2021: Age, Sex, and Risk Factors in a Global Context.

Sep 2026 · Nicotine & Tobacco Research · 0 citations
Medicine

TL;DR

From 1990 to 2021, China experienced faster declines in standardized smoking burden than the global average, yet its absolute burden and global share increased substantially, suggesting sustained, targeted tobacco control-especially among older males and for cancer prevention-is urgently needed.

Abstract

INTRODUCTION Smoking remains one of the leading preventable causes of morbidity and mortality worldwide. Understanding long-term trends in smoking-related diseases is essential for evaluating policy effectiveness and guiding prevention efforts. This study assessed the burden of disease attributable to smoking in China from 1990 to 2021, comparing its trends with global and sociodemographic index (SDI) patterns to identify policy priorities.

Methods

Age-, sex-, and SDI-stratified analyses were conducted using mortality and disability-adjusted life years (DALYs) data from the Global Burden of Disease Study 2021. Temporal trends were evaluated with Joinpoint regression and multiple visualization methods.

Results

Globally, age-standardized smoking-attributable death rates declined, but China showed a steeper decline (average annual percent change = -2.00 vs. -1.77). However, China's absolute smoking-related deaths rose by 57.5% to 2.30 million in 2021, accounting for 37.3% of the global total. Males bore a disproportionately higher burden, with an age-standardized death rate nearly 10 times that of females. Burden peaked at ages 65-74 for death counts and at ages 90-94 for rates. Unlike the global pattern where cardiovascular diseases dominate, neoplasms were the leading cause in China. Age-standardized DALYs rates for diabetes and kidney diseases showed a rising trend.

Conclusion

From 1990 to 2021, China experienced faster declines in standardized smoking burden than the global average, yet its absolute burden and global share increased substantially. Sustained, targeted tobacco control-especially among older males and for cancer prevention-is urgently needed.

View source

Similar papers

Open access Sep 2026

Tobacco-driven digestive disease burden: A China–US comparative analysis, 1990–2035

Introduction Smoking is a well-established risk factor for digestive diseases, yet direct comparisons of smoking-attributable digestive disease burden between nations with divergent tobacco control trajectories remain scarce. This study compared temporal trends, driving factors, and future projections of this burden in...

Zhuo-Fu Cheng, Xue Luo, Da Yan et al. · 0 citations
Open access Sep 2026

Tobacco-attributable mortality and disease burden in India: a descriptive analysis of Global Burden of Disease 2023 estimates for 1990 and 2023

Objectives Tobacco use remains a major contributor to mortality and disability in India. This study assessed tobacco-attributable mortality and disability-adjusted life-years (DALYs) in India in 1990 and 2023, with comparisons by sex, age group and type of tobacco exposure. Design Descriptive population-level analysis...

Chaitali Mandal, Mayank Singh, Murali Dhar · 0 citations
Aug 2026

Burden of Stroke and Its Subtypes in Young Adults in China: A Systematic Analysis from 1990 to 2023 and Projections to 2050.

Global and Chinese overall stroke age-standardized incidence rates declined, but new cases increased globally, and ischemic stroke age-standardized incidence rose significantly in China, and China's proportion of global cases and deaths decreased.

Fei-Hong Hu, Hai-Lin Lu, Hong Xu et al. · 0 citations
Open access Sep 2026

Trends, Persistent Disability Burden, and Priority Risk Factors of Stroke in China from 1990 to 2023: Evidence from GBD 2023.

BACKGROUND Stroke remains a major cause of death and disability in China. We assessed whether declining fatal burden was accompanied by improvement in non-fatal disability and characterized updated attributable risks. METHODS Global Burden of Disease Study 2023 estimates for China during 1990-2023 were analyzed for a...

Hong-Jian Wen, Xiao-Rong Jiang, Cui-Xiu Qin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.